(BUD) Anheuser Busch Inbev - Ratings and Ratios

Exchange: NYSE • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: US03524A1088

Beer, Spirits, Canned, Non-Alcoholic

Brewers
Market Cap in USD: 128,217m

IPO / Inception: 2009-07-01
12m vs SPY: 21.2%

EPS (Earnings per Share)

EPS CAGR: -43.00%
EPS Trend: -12.1%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -15.51%
Rev. Trend: -12.6%

Last SUE: -0.02
Qual. Beats: 0

Dividends

Dividend Yield	1.92%
Yield on Cost 5y	1.92%
Yield CAGR 5y	20.34%
Payout Consistency	90.4%
Payout Ratio	34.2%

Risk via 5d forecast
Volatility	22.1%
Value at Risk 5%th	34.0%
Relative Tail Risk	-6.58%

Reward TTM
Sharpe Ratio	1.54
Alpha	30.98
CAGR/Max DD	0.15

Character TTM
Hurst Exponent	0.496
Beta	0.242
Beta Downside	0.116

Drawdowns 3y
Max DD	31.55%
Mean DD	9.98%
Median DD	9.56%

Description: BUD Anheuser Busch Inbev December 02, 2025

Anheuser-Busch InBev (NYSE:BUD) is a global brewer headquartered in Leuven, Belgium, with a portfolio of roughly 500 brands-including Budweiser, Corona Extra, Stella Artois, and Michelob Ultra-sold across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The company also markets spirits-based ready-to-drink and non-alcoholic beverages.

Key metrics as of FY 2023: revenue of $57 billion, adjusted EBITDA margin of 18 %, and net debt-to-EBITDA of 3.2×, reflecting a balance-sheet still leveraged after the 2022-23 debt-reduction program. Growth is being driven by premiumization (e.g., higher-margin craft and imported brands), a 7 % increase in on-trade volume in emerging markets, and a 4 % rise in e-commerce sales of RTD products, while commodity price volatility and shifting consumer preferences toward low-alcohol options remain material risks.

For a deeper, data-rich analysis of BUD’s valuation dynamics, you might explore the company’s profile on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (9.85b TTM) > 0 and > 6% of Revenue (6% = 5.32b TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 0.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -11.36% (prev -39.36%; Δ 28.01pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 15.19b > Net Income 9.85b (YES >=105%, WARN >=100%)

Net Debt (61.00b) to EBITDA (24.56b) ratio: 2.48 <= 3.0 (WARN <= 3.5)

Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.79% (target <= -2.0% for YES)

Gross Margin 55.92% (prev 45.83%; Δ 10.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 41.62% (prev 34.18%; Δ 7.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.79 (EBITDA TTM 24.56b / Interest Expense TTM 8.48b) >= 6 (WARN >= 3)

Altman Z'' 1.61

(A) -0.05 = (Total Current Assets 23.00b - Total Current Liabilities 33.07b) / Total Assets 206.64b

(B) 0.23 = Retained Earnings (Balance) 46.58b / Total Assets 206.64b

(D) 0.68 = Book Value of Equity 80.67b / Total Liabilities 117.94b

Total Rating: 1.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.70

1. Piotroski 6.0pt

2. FCF Yield 6.04%

3. FCF Margin 13.14%

4. Debt/Equity 0.79

5. Debt/Ebitda 2.48

6. ROIC - WACC (= 2.16)%

7. RoE 11.62%

8. Rev. Trend -12.57%

9. EPS Trend -12.10%

What is the price of BUD shares?

As of January 13, 2026, the stock is trading at USD 66.74 with a total of 1,506,371 shares traded.
Over the past week, the price has changed by +5.48%, over one month by +4.71%, over three months by +12.66% and over the past year by +46.59%.

Is BUD a buy, sell or hold?

Anheuser Busch Inbev has received a consensus analysts rating of 4.15. Therefore, it is recommended to buy BUD.

Strong Buy: 5
Buy: 5
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the BUD price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	76.9	15.2%
Analysts Target Price	76.9	15.2%
ValueRay Target Price	70.4	5.4%

BUD Fundamental Data Overview January 12, 2026

P/E Trailing = 21.887
P/E Forward = 15.7729
P/S = 2.1878
P/B = 1.5894
P/EG = 1.3211
Beta = 0.679
Revenue TTM = 88.66b USD
EBIT TTM = 15.19b USD
EBITDA TTM = 24.56b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 193.02b USD (128.22b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 1.79 (Ebit TTM 15.19b / Interest Expense TTM 8.48b)
EV/FCF = 16.57x (Enterprise Value 193.02b / FCF TTM 11.65b)
FCF Yield = 6.04% (FCF TTM 11.65b / Enterprise Value 193.02b)
FCF Margin = 13.14% (FCF TTM 11.65b / Revenue TTM 88.66b)
Net Margin = 11.10% (Net Income TTM 9.85b / Revenue TTM 88.66b)
Gross Margin = 55.92% ((Revenue TTM 88.66b - Cost of Revenue TTM 39.08b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.93 (Enterprise Value 193.02b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 10.31b (EBIT 15.19b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 2.48 (Net Debt 61.00b / EBITDA 24.56b)
Debt / FCF = 5.24 (Net Debt 61.00b / FCF TTM 11.65b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.62% (Net Income 9.85b / Total Assets 206.64b)
RoE = 11.62% (Net Income TTM 9.85b / Total Stockholder Equity 84.76b)
RoCE = 9.88% (EBIT 15.19b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 6.83% (NOPAT 10.31b / Invested Capital 151.01b)
WACC = 4.66% (E(128.22b)/V(200.39b) * Re(6.81%) + D(72.17b)/V(200.39b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 86.31% ; FCFF base≈11.26b ; Y1≈11.23b ; Y5≈11.83b
Fair Price DCF = 169.3 (EV 352.96b - Net Debt 61.00b = Equity 291.97b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: -12.10 | EPS CAGR: -43.00% | SUE: -4.0 | # QB: 0
Revenue Correlation: -12.57 | Revenue CAGR: -15.51% | SUE: -0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+12.8% | Growth Revenue=+5.5%

Additional Sources for BUD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle